Education
About Us
Working with TipRanks
Follow Us
Novartis (CH:NOVN)
:NOVN
NOVN Analyst Ratings
Hold
4 Buy
7 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NOVN Stock 12 Month Forecast
Average Price Target
CHF101.00
▲(2.94% Upside)
| Highest Price TargetCHF115.00 | Average Price TargetCHF101.00 | Lowest Price TargetCHF86.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Deutsche Bank
Reiterated
03/21/25
Kepler Capital
Reiterated
03/21/25
Berenberg Bank
Reiterated
03/14/25
J.P. Morgan
Reiterated
02/25/25
Bernstein
Reiterated
02/20/25
Morgan Stanley
Initiated
02/12/25
Goldman Sachs
Reiterated
02/11/25
DZ BANK AG
Reiterated
02/03/25
Bank of America Securities
Reiterated
02/03/25
Barclays
CHF85→CHF90
Sell
-8.28%
Downside
Reiterated
02/03/25
Novartis AG (NOVN) Receives a Sell from Barclays
Jefferies
CHF100
Hold
1.92%
Upside
Reiterated
01/31/25
Novartis AG (NOVN) Gets a Hold from Jefferies
Stifel Nicolaus
CHF109
Hold
11.09%
Upside
Reiterated
01/31/25
Novartis AG: Balancing Strong Performance with Future Challenges - Hold Rating Maintained
HSBC
CHF95→CHF82
Sell
-16.43%
Downside
Downgraded
12/04/24
Novartis downgraded to Reduce from Hold at HSBCNovartis downgraded to Reduce from Hold at HSBC
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Deutsche Bank
Reiterated
03/21/25
Kepler Capital
Reiterated
03/21/25
Berenberg Bank
Reiterated
03/14/25
J.P. Morgan
Reiterated
02/25/25
Bernstein
Reiterated
02/20/25
Morgan Stanley
Initiated
02/12/25
Goldman Sachs
Reiterated
02/11/25
DZ BANK AG
Reiterated
02/03/25
Bank of America Securities
Reiterated
02/03/25
Barclays
CHF85→CHF90
Sell
-8.28%
Downside
Reiterated
02/03/25
Novartis AG (NOVN) Receives a Sell from Barclays
Jefferies
CHF100
Hold
1.92%
Upside
Reiterated
01/31/25
Novartis AG (NOVN) Gets a Hold from Jefferies
Stifel Nicolaus
CHF109
Hold
11.09%
Upside
Reiterated
01/31/25
Novartis AG: Balancing Strong Performance with Future Challenges - Hold Rating Maintained
HSBC
CHF95→CHF82
Sell
-16.43%
Downside
Downgraded
12/04/24
Novartis downgraded to Reduce from Hold at HSBCNovartis downgraded to Reduce from Hold at HSBC
NOVN Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
11
9
9
10
14
Hold
23
21
22
22
17
Sell
4
6
5
5
2
Strong Sell
0
0
0
0
0
total
38
36
36
37
33
Each month's total comprises the sum of three months' worth of ratings.
NOVN Financial Forecast
NOVN Stock Forecast FAQ
What is CH:NOVN’s average 12-month price target, according to analysts?
Based on analyst ratings, Novartis’s 12-month average price target is CHF101.00.
What is CH:NOVN’s upside potential, based on the analysts’ average price target?
Novartis has 2.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novartis a Buy, Sell or Hold?
Novartis has a consensus rating of Hold, which is based on 4 buy ratings, 7 hold ratings and 2 sell ratings.
What is Novartis’s share price target?
The average share price target for Novartis is CHF101.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF115.00 ,and the lowest forecast is CHF86.00. The average share price target represents 2.94% Increase from the current price of CHF98.12.
The highest analyst share price target is CHF115.00 ,and the lowest forecast is CHF86.00. The average share price target represents 2.94% Increase from the current price of CHF98.12.
What do analysts say about Novartis?
Novartis’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Novartis?
To buy shares of CH:NOVN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.